MarketSmith India Stock Picks for 1 October and Market Overview

MarketSmith India has released its stock recommendations for 1 October, offering investors guidance amid a challenging market environment. The advisory highlights two promising stocks: Madhya Bharat Agro Products Limited and Molbio Diagnostics Limited. These picks come at a time when Indian markets have experienced notable volatility, with indices showing downward trends after a tough September.

On 30 September, Indian equity benchmarks declined for the third consecutive session. The Nifty 50 index dropped by 95.75 points, or 0.42%, closing at 22,620.45, marking its lowest level in roughly six months. The Sensex also slipped 48.78 points, or 0.07%, to finish at 72,480.29. Early trade gains, supported by easing crude oil prices and reduced expectations of aggressive U.S. Federal Reserve interest rate hikes, were wiped out by selling pressures in pharmaceutical and metal sectors.

Sector-wise, healthcare stocks were the most affected, falling by 2.35%. Consumer durables and metals also faced declines. Conversely, banking shares helped cushion the fall, with the Nifty Bank index advancing 0.69% ahead of upcoming quarterly earnings reports. Auto stocks similarly ended in positive territory. Railways stocks, including IRCTC, RVNL, and Ircon, recorded gains of up to 14% on heavy volumes.

September was a difficult month overall for the Nifty 50, which lost about 6%, pressured by high crude oil prices, rising bond yields, and significant foreign capital outflows. Market breadth was slightly negative with 1,813 stocks declining versus 1,740 advancing.

Madhya Bharat Agro Products Limited is one of the recommended buys, trading around ₹171. The company operates a backward-integrated fertilizer business, producing products from rock phosphate through to SSP, DAP, and NPK fertilizers. This integration aids margin improvement and helps maintain supply chain stability. Increasing fertilizer demand supports volume growth, while ongoing capacity expansion at the Dhule plant and a widespread distribution network across multiple Indian states provide opportunities for revenue growth.

Key financials include a price-to-earnings ratio of 49.41 and a 52-week high near ₹174.94. The stock recently showed a trendline breakout on technical charts. However, risks include sensitivity to raw material price fluctuations, such as rock phosphate, sulphur, and phosphoric acid, as well as potential changes in government fertilizer subsidy policies. Additionally, demand can be affected by monsoon performance and farm economics. MarketSmith suggests a buying range between ₹169 and ₹172, targeting ₹195 within two to three months. A stop loss is advised at ₹162.

The second recommended stock, Molbio Diagnostics Limited, is priced around ₹1,310. Molbio is known for its proprietary Truenat molecular diagnostics platform, which generates recurring revenue through test kits and consumables, providing a scalable growth model with high margins. The company is expanding internationally and diversifying its product portfolio into infectious diseases, digital pathology, and portable radiology, indicating strong long-term potential.

Molbio’s valuation metrics show no P/E due to current earnings status, with a 52-week high at ₹1,686.80 and a recent trading volume of ₹409.08 crore. The stock also exhibits a trendline breakout. Potential risks include revenue concentration around the Truenat platform and infectious disease testing, creating dependence on a limited ecosystem. Heavy reliance on government and institutional healthcare procurement introduces pricing and regulatory uncertainties. The recommended buy range is ₹1,297 to ₹1,317, with a target price of ₹1,700 over two to three months and a stop loss set at ₹1,195.

Technical analysis of the Nifty 50 reveals a bearish trend. The index has formed lower highs and lower lows, trading below key moving averages. The relative strength index (RSI) has dropped below 30 to 25.27, signaling oversold conditions but no clear bullish reversal yet. The moving average convergence divergence (MACD) indicator remains negative, confirming ongoing downward momentum.

Support levels for the Nifty 50 are identified between 22,600 and 22,500. A sustained break below this range could accelerate selling pressure, potentially pushing the index toward 22,200 or even 22,000. Resistance is expected near 23,000 to 23,100, which the index must overcome to suggest any short-term recovery.

The Nifty Bank index showed some resilience, closing up 0.69% at 54,633.05 after recovering from early losses. Despite this, the sector remains under pressure, trading below all major moving averages and displaying weak momentum indicators. Immediate support lies in the 54,175 to 54,000 zone, with resistance near 55,135 followed by higher moving average levels. The banking sector faces challenges from rising crude prices, a weak rupee, elevated global yields, and ongoing foreign selling, although domestic liquidity may provide some cushion.

MarketSmith India operates as a specialized research platform focused on the Indian stock market, using the CAN SLIM investment methodology developed by William J. O’Neil. Investors can access a 10-day free trial by registering on their website. The company, known officially as William O’Neil India Pvt. Ltd., holds SEBI registration number INH000015543.

These stock recommendations and market insights serve as a resource for investors aiming to make informed decisions in a complex market environment. However, MarketSmith India advises consulting certified financial experts before acting on any investment guidance.